|
|
||||||||






*
Medizinische Klinik II, Hämatologie-Onkologie, Krankenhaus Nordwest, Frankfurt, Germany;
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213;
Istituto Tumori Milano, Milano, Italy;
Department of Medical Microbiology, University of Mainz, Hochhaus Augustusplatz, Mainz, Germany; and
¶ Immunomics Operations, Beckman Coulter, Marseille, France
Soluble MHC class I molecules loaded with antigenic peptides are
available either to detect and to enumerate or, alternatively, to sort
and expand MHC class I-restricted and peptide-reactive T cells. A
defined number of MHC class I/peptide complexes can now be implemented
to measure T cell responses induced upon Ag-specific stimulation,
including CD3/CD8/
-chain down-regulation, pattern, and quantity of
cytokine secretion. As a paradigm, we analyzed the reactivity of a
Melan-A/MART-1-specific and HLA-A2-restricted CD8+ T
cell clone to either soluble or solid-phase presented peptides,
including the naturally processed and presented Melan-A/MART-1 peptide
AAGIGILTV or the peptide analog ELAGIGILTV presented either by the
HLA-A2 wild-type (wt) or mutant (alanine
valine aa 245) MHC class I
molecule, which reduces engagement of the CD8 molecule with the HLA-A2
heavy chain. Soluble MHC class I complexes were used as either
monomeric or tetrameric complexes. Soluble monomeric MHC class I
complexes, loaded with the Melan-A/MART-1 peptide, resulted in CD3/CD8
and TCR
-chain down-regulation, but did not induce measurable
cytokine release. In general, differences pertaining to
CD3/CD8/
-chain regulation and cytokine release, including IL-2,
IFN-
, and GM-CSF, were associated with 1) the format of Ag
presentation (monomeric vs tetrameric MHC class I complexes), 2) wt vs
mutant HLA-A2 molecules, and 3) the target Ag (wt vs analog peptide).
These differences are to be considered if T cells are exposed to
recombinant MHC class I Ags loaded with peptides implemented for
detection, activation, or sorting of Ag-specific T
cells.
This article has been cited by other articles:
![]() |
J. Yuan, J.-B. Latouche, J. Hodges, A. N. Houghton, G. Heller, M. Sadelain, I. Riviere, and J. W. Young Langerhans-Type Dendritic Cells Genetically Modified to Express Full-Length Antigen Optimally Stimulate CTLs in a CD4-Dependent Manner J. Immunol., February 15, 2006; 176(4): 2357 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dutoit, P. Guillaume, M. Ayyoub, C. S. Hesdorffer, I. F. Luescher, and D. Valmori Decreased Binding of Peptides-MHC Class I (pMHC) Multimeric Complexes to CD8 Affects Their Binding Avidity for the TCR But Does Not Significantly Impact on pMHC/TCR Dissociation Rate J. Immunol., May 15, 2003; 170(10): 5110 - 5117. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |